Evidence map›Paper›PMID 37128253›Full record

ArticleRadiology case reports2023

Hemolytic uremic syndrome with central nervous system manifestations, a case report and literature review.

Moustafa A Mansour, Dyana F Khalil, Mohab A Hasham, Ahmed Youssef, Mohamed Rashad, Muhammad Awadallah, Hassan Ali

Open access · goldAbstract readCase Reports
In one paragraph

Article in Radiology case reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Shiga Toxin Induces ApoptosisJournal of microbiology and biotechnology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 2 countries.

Moustafa A MansourDepartment of Neurology and Neurologic Surgery, Faculty of Medicine, Al-Azhar University, 1 Al-Mokhyam Al-Daem St., Nasr City, Cairo 11884, Egypt.
Dyana F KhalilDepartment of Emergency Medicine and Critical Care, Dubai Healthcare City, Dubai, UAE.
Mohab A HashamDepartment of Emergency Medicine and Critical Care, Faculty of Medicine, Al-Azhar University, 1 Al-Mokhyam Al-Daem St., Nasr City, Cairo 11884, Egypt.
Ahmed YoussefDepartment of Emergency Medicine and Critical Care, Faculty of Medicine, Al-Azhar University, 1 Al-Mokhyam Al-Daem St., Nasr City, Cairo 11884, Egypt.
Mohamed RashadDepartment of Pediatrics, Faculty of Medicine, Al-Azhar University, Cairo, Egypt.
Muhammad AwadallahDepartment of Pediatrics, Faculty of Medicine, Al-Azhar University, Cairo, Egypt.
Hassan AliDepartment of Pediatrics, Faculty of Medicine, Al-Azhar University, Cairo, Egypt.
Al-Azhar University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hemolytic uremic syndrome (HUS) is a multisystem disorder generally seen in children and young adults, manifesting with the symptomatic triad of thrombocytopenia, hemolytic anemia, and acute kidney injury. These symptoms are often preceded by a prodrome of bloody diarrhea, vomiting, fever, and weakness. HUS is an exceedingly rare entity, with less than 1.5 per 100,000 people affected annually. HUS with central nervous system (CNS) manifestations constitutes approximately 20%-50% of cases and often presents with seizures, altered level of consciousness, and brainstem symptoms. CNS involvement in HUS is a major cause of acute morbidity and mortality; therefore, timely diagnosis and treatment are crucial in the management of these cases. Neuroimaging plays a critical role in the diagnosis; however, it might be very challenging in a large number of cases because studies that report the typical neuroradiologic features of brain injury in cases with HUS are not commonly available. Herein, we demonstrate in a case-based approach, the importance of combining clinical suspicion with different radiologic modalities to better characterize HUS cases with CNS involvement, as well as demonstrate how the early start of meticulous supportive therapy can lead to a favorable outcome even when severe brain involvement is evident on acute imaging studies. Furthermore, we provide an illustrated overview of the current theories that explain the neurologic involvement in HUS, as well as the commonly affected brain areas and how this entity can be radiologically differentiated from other potential diagnoses.

Indexed as

Basal gangliaBrain edemaCNS manifestations in hemolytic uremic syndromeDiagnostic imaging/neuroradiologyHemolytic uremic syndromeIntensive care unit/neuro ICU

Identifiers

PMID37128253
PMCPMC10147953
OpenAlexW4366258469

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.